SPIA
EWTX icon

Steward Partners Investment Advisory’s Edgewise Therapeutics EWTX Stock Holding History

Steward Partners Investment Advisory’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$74.2K Sell
2,354
-500
-18% -$14.4K ﹤0.01% 2559
2025
Q4 		$70.8K Buy
2,854
+550
+24% +$11K ﹤0.01% 2489
2025
Q3 		$37.4K Buy
+2,304
New +$32.7K ﹤0.01% 2755

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Steward Partners Investment Advisory's EWTX Position: Q1 2026 in Review

Steward Partners Investment Advisory reduced its Edgewise Therapeutics (EWTX) stake by 18% in Q1 2026, selling an estimated $14.4K and leaving 2,354 shares worth $74.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2559.

Steward Partners Investment Advisory first reported a position in EWTX in Q3 2025 and has held it in 3 quarters since. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Steward Partners Investment Advisory held 2,354 shares of Edgewise Therapeutics worth $74.2K as of Q1 2026.
  • Steward Partners Investment Advisory sold 500 Edgewise Therapeutics shares in Q1 2026, an estimated $14.4K.
  • Edgewise Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #2559 holding.
  • Steward Partners Investment Advisory first reported a position in Edgewise Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.